Brent E. Korba
Department of Microbiology and Immunology
Georgetown University Medical Center
Washington
DC 20057
USA
Name/email consistency: high
- Potential for hepatitis C virus resistance to nitazoxanide or tizoxanide. Korba, B.E., Elazar, M., Lui, P., Rossignol, J.F., Glenn, J.S. Antimicrob. Agents Chemother. (2008)
- Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication. Korba, B.E., Montero, A.B., Farrar, K., Gaye, K., Mukerjee, S., Ayers, M.S., Rossignol, J.F. Antiviral Res. (2008)
- Clevudine: a potent inhibitor of hepatitis B virus in vitro and in vivo. Korba, B.E., Furman, P.A., Otto, M.J. Expert. Rev. Anti. Infect. Ther (2006)
- Clevudine therapy with vaccine inhibits progression of chronic hepatitis and delays onset of hepatocellular carcinoma in chronic woodchuck hepatitis virus infection. Korba, B.E., Cote, P.J., Menne, S., Toshkov, I., Baldwin, B.H., Wells, F.V., Tennant, B.C., Gerin, J.L. Antivir. Ther. (Lond.) (2004)